News

Smoking Cessation and Nicotine Addiction Market is Projected to Grow at a CAGR of 2.6% During the Study Period (2019-2032)

by

The smoking cessation and nicotine addiction market is projected to grow positively owing to the increasing R&D activities, healthcare spending, and the expected launch of emerging therapies by leading players such as Achieve Life Sciences, NFL Biosciences SAS, Embera NeuroTherapeutics, Inc, Axsome Therapeutics, and others. LAS VEGAS, May 15, 2023 /PRNewswire/ — DelveInsight’s Smoking Cessation … Read more

Alife Health Launches Mobile App to Help Patients Navigate their IVF Journey

by

The Alife app offers easy-to-use tracking, reminders, educational resources, and personalized timelines to support patients through the IVF process. SAN FRANCISCO, May 15, 2023 /PRNewswire/ — Alife Health, a technology company building AI tools to advance fertility care, announced today the launch of its mobile application to help patients navigate their IVF journey from beginning … Read more

Dasa Expands Its Capabilities with SOPHiA GENETICS

by

In just one year of using SOPHiA DDM™ HRD, Dasa reaches 2,000 samples analyzed BOSTON and LAUSANNE, Switzerland, May 8, 2023 /PRNewswire/ — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and the leader in data-driven medicine, celebrates today with longstanding partner, Dasa, the largest integrated healthcare network in Brazil, as it reaches a milestone of … Read more

Regenerative Medicine Market to Reach a Valuation of USD 127.86 Billion by 2032, Backed by Advancement in Cell Therapy, States Extrapolate

by

DUBAI, UAE, May 15, 2023 /PRNewswire/ — According to the latest research report published by Extrapolate, the global Regenerative Medicine Market is poised to experience substantial growth and accrue a market size of USD 127.86 billion by 2032, recording a CAGR of 17% between 2023 and 2032. This is a significant increase from the base … Read more

Ambulatory Polysomnography (PSG) Systems Market to Reach $570.7 Million, Globally, by 2031 at 6.0% CAGR: Allied Market Research

by

The expansion of the ambulatory polysomnography (PSG) systems market is heavily influenced by the incidence of various sleep disorders, which creates attractive prospects for market growth. The North America region is projected to garner the highest revenue by 2031. PORTLAND, Ore., May 15, 2023 /PRNewswire/ — Allied Market Research published a report, titled, “Ambulatory Polysomnography … Read more

Cascade Health Announces Venture Funding Round to Build Intelligent Platform for Healthcare Transparency

by

Company’s advanced generative AI-powered cloud platform creates clarity around healthcare pricing, coverage for consumers, employers, government agencies, hospitals, insurance companies and other businesses in the healthcare industry SEATTLE, May 15, 2023 /PRNewswire/ — Cascade Health, an intelligent platform for healthcare transparency, announced it has raised $1.7 million in venture funding led by AlleyCorp with participation … Read more

Survey Finds that Americans Know They Feel Their Best and Have Reduced Stress After Getting a Good Night’s Rest

by

Natrol is on a Mission This Mental Health Awareness Month to Help Consumers Break the Sleep Stress Cycle Through New “Wake Up Call” Campaign SHERMAN OAKS, Calif., May 15, 2023 /PRNewswire/ — A recent survey* of the Sleep Stress Cycle taken by 2,000 adults shows that 9 out of 10 (92%) agree they’re less stressed … Read more

Alliance Creative Group (ACGX) Reports First Quarter of 2023 Financials with Over $4,000,000 in assets

by

The transition for ACG is making progress in 2023 CHICAGO, May 15, 2023 /PRNewswire/ — Alliance Creative Group, Inc., (http://www.AllianceCreativeGroup.com) (Stock Symbol OTC: ACGX) is pleased to announce the results of Operations for the Three Months and Quarter Ending March 31, 2023. Revenues for the quarter ending March 31, 2023 (“Q1 2023”) were $845,676 Gross … Read more

Emmaus Life Sciences Reports Q1 2023 Financial Results and Provides Business Update

by

TORRANCE, Calif., May 15, 2023 /PRNewswire/ — Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of operations as of and for the three months ended March 31, 2023. Recent Highlights “We enjoyed a fifth straight increase in … Read more

Lipella Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Update

by

Successful top line results from Phase 2a clinical trial for lead candidate LP-10 Oral Health Scientific Advisory Board established to focus on development of LP-310 for oral lichen planus Late-breaking presentation of Phase 2a study results at the American Urological Association Annual Meeting Manufacturing collaboration agreement with Cook MyoSite in anticipation of Lipella’s forthcoming Investigational … Read more